---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-034475"
form_type: "8-K"
ticker: "CSBR"
cik: "0000771856"
company_name: "CHAMPIONS ONCOLOGY, INC."
filed_at: "2023-10-17T23:59:59+00:00"
generated_at: "2026-06-09T22:58:51.965972+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Champions Oncology appoints Brady Davis as President, effective Oct 9, 2023

## Summary
- Brady Davis appointed President; annual base salary of $425,000 plus 50% target bonus.
- Davis receives 135,000 stock options vesting over 4 years and 7,500 vesting over 1 year.
- Davis brings 25+ years experience from Illumina, Oracle, Hewlett Packard, DNAnexus, and Canexia Health.

## SEC filing metadata
- accession: 0001628280-23-034475
- form_type: 8-K
- ticker: CSBR
- cik: 0000771856
- company_name: CHAMPIONS ONCOLOGY, INC.
- filed_at: 2023-10-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771856/000162828023034475/0001628280-23-034475-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771856/000162828023034475/csbr-20231009.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-034475
- JSON: https://secwatch.observer/filing/0001628280-23-034475.json
- Plain text: https://secwatch.observer/filing/0001628280-23-034475.txt

## Key facts
- Executive change
  Brady Davis was appointed as President at CHAMPIONS ONCOLOGY, INC..
  - Action: appointed
  - Role: President
  source text: On October 17, 2023, Champions Oncology, Inc. (the “Company”) announced the hiring and appointment of Brady Davis to serve as the Company’s President, effective as of October 9, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/771856/000162828023034475/0001628280-23-034475-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.